SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-195008
Filing Date
2014-05-12
Accepted
2014-05-12 16:51:43
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d712259d10q.htm 10-Q 762183
2 EX-31.1 d712259dex311.htm EX-31.1 8313
3 EX-31.2 d712259dex312.htm EX-31.2 8197
4 EX-32.1 d712259dex321.htm EX-32.1 4309
11 GRAPHIC g712259g38s74.jpg GRAPHIC 93199
  Complete submission text file 0001193125-14-195008.txt   4873480

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT enta-20140331.xml EX-101.INS 693693
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20140331.xsd EX-101.SCH 37490
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20140331_cal.xml EX-101.CAL 55997
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20140331_def.xml EX-101.DEF 133644
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20140331_lab.xml EX-101.LAB 347844
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20140331_pre.xml EX-101.PRE 241802
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 14834018
SIC: 2834 Pharmaceutical Preparations